Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1456 to 1470 of 2186 results for guidelines

  1. PredictSURE IBD and IBDX to guide treatment of Crohn's disease (HTG610)

    Evidence-based recommendations on PredictSURE IBD and IBDX for guiding treatment of Crohn’s disease.

    HealthTech guidance
    Published
    23 February 2022
    View recommendations

    Sections for HTG610

  2. Methods research areas

    NICE priority methodological research areas.

  3. Ultrasound‑enhanced, catheter‑directed thrombolysis for pulmonary embolism (HTG376)

    Evidence-based recommendations on ultrasound enhanced catheter-directed thrombolysis for pulmonary embolism. This involves using ultrasound waves and a drug to break up the clot.

    HealthTech guidance
    Published
    26 June 2015
    View recommendations

    Sections for HTG376

  4. What are the clinical and cost effectiveness, and the safety, of specific antifungal treatments for treating suspected or confirmed COVID-19-associated pulmonary aspergillosis (CAPA), and the optimal treatment duration? When should treatment be started, stopped or modified?

    Source guidance details Comes from guidance COVID-19 rapid guideline: managing COVID-19 Number NG191 Date issued March

    Research recommendation
    Published
    9 March 2022

  5. Patient self-management plans:- What is the clinical and cost effectiveness of a self-management plan for people with stable angina?

    This research would inform future updates of key recommendations in the guideline. Furthermore the research would be relevant to a...

    Research recommendation
    Published
    9 June 2015

  6. Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDs (TA537)

    Evidence-based recommendations on ixekizumab (Taltz) for treating active psoriatic arthritis in adults.

    Technology appraisal guidance
    Published
    8 August 2018
    View recommendations

    Sections for TA537

  7. Ustekinumab for treating moderate to severe plaque psoriasis (TA180)

    Evidence-based recommendations on ustekinumab (Stelara) for treating psoriasis in adults.

    Technology appraisal guidance
    Last updated
    3 March 2017
    View recommendations

    Sections for TA180

  8. Which of the electronic information-sharing systems perform best for the care of people approaching the end of their life?

    end of their life? Any explanatory notes(if applicable) The guideline committee made recommendations on sharing information about people...

    Research recommendation
    Published
    18 November 2019

  9. Predictors of acute physical risk:- What clinical and biochemical markers are the best predictors of acute physical risk for people with eating disorders?

    nutrition). The medical markers of acute risk are used throughout this guideline. Despite their importance, almost all of the...

    Research recommendation
    Published
    12 October 2018

  10. Hearing loss prevalence in people who under-present for hearing loss:- What is the prevalence of hearing loss among populations who under-present for possible hearingloss?

    consider the possibility of hearing loss.The evidence review for the NICE guideline on adult hearing loss highlighted significant health...

    Research recommendation
    Published
    10 December 2018

  11. Advocacy and support for decision-making:- What is the effectiveness, cost effectiveness and acceptability of advocacy as a means of supporting people to make decisions?

    advocacy as a means of supporting people to make decisions. However, the guideline committee thought that this was an area in which...

    Research recommendation
    Published
    18 December 2018

  12. Coronary revascularisation: Cangrelor (ESNM63)

    Summary of the evidence on cangrelor for coronary revascularisation to inform local NHS planning and decision-making

    Evidence summary
    Published
    3 November 2015

  13. Training and support for practitioners:- What is the effectiveness and cost effectiveness of different training programmes on the Mental Capacity Act 2005 at improving practice for practitioners involved in supporting decision-making, conducting capacity assessments and making best interests decisions?

    Any explanatory notes(if applicable) Why this is important:- The guideline committee agreed that effective training and support on the...

    Research recommendation
    Published
    19 December 2018

  14. Maintaining the benefits of early intervention in psychosis services after discharge:- How can the benefits of early intervention in psychosis services be maintained once service users are discharged after 3 years?

    care or community mental health services these gains are diminished. The guideline recommends that trusts consider extending these...

    Research recommendation
    Published
    9 June 2015

  15. Ultrasound‑enhanced, catheter‑directed thrombolysis for deep vein thrombosis (HTG375)

    Evidence-based recommendations on ultrasound enhanced catheter-directed thrombolysis for deep vein thrombosis. This involves using ultrasound waves and a drug to break up the clot.

    HealthTech guidance
    Published
    26 June 2015
    View recommendations

    Sections for HTG375